Joel M. Mor

417 total citations
28 papers, 249 citations indexed

About

Joel M. Mor is a scholar working on Ophthalmology, Surgery and Dermatology. According to data from OpenAlex, Joel M. Mor has authored 28 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 8 papers in Surgery and 7 papers in Dermatology. Recurrent topics in Joel M. Mor's work include Ocular Oncology and Treatments (9 papers), Ocular Disorders and Treatments (6 papers) and Nonmelanoma Skin Cancer Studies (5 papers). Joel M. Mor is often cited by papers focused on Ocular Oncology and Treatments (9 papers), Ocular Disorders and Treatments (6 papers) and Nonmelanoma Skin Cancer Studies (5 papers). Joel M. Mor collaborates with scholars based in Germany, United States and Switzerland. Joel M. Mor's co-authors include Ludwig M. Heindl, Konrad R. Koch, Alexander C. Rokohl, Yongwei Guo, Niklas Loreck, Friederike Schaub, Keith R. Pine, Werner Adler, Olaf Wolkenhauer and Brigitte Vollmar and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Plastic & Reconstructive Surgery and The Journal of Pathology.

In The Last Decade

Joel M. Mor

25 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel M. Mor Germany 10 116 70 56 51 48 28 249
Hailah Al‐Hussain Saudi Arabia 7 120 1.0× 54 0.8× 44 0.8× 22 0.4× 40 0.8× 13 221
Chaiwat Teekhasaenee Thailand 11 329 2.8× 87 1.2× 26 0.5× 39 0.8× 53 1.1× 22 472
Machteld I. Bosscha Netherlands 9 122 1.1× 59 0.8× 9 0.2× 31 0.6× 51 1.1× 18 237
CarolL Shields United States 10 296 2.6× 26 0.4× 15 0.3× 79 1.5× 23 0.5× 19 354
Simon Hardman‐Lea United Kingdom 6 141 1.2× 19 0.3× 53 0.9× 46 0.9× 108 2.3× 9 290
Eva-Marie Chong United States 8 132 1.1× 15 0.2× 13 0.2× 38 0.7× 34 0.7× 8 296
Paul R. Austin United States 4 83 0.7× 28 0.4× 55 1.0× 35 0.7× 17 0.4× 4 246
Clélia Maria Erwenne Brazil 9 255 2.2× 28 0.4× 17 0.3× 95 1.9× 45 0.9× 37 319
Hans Mittelviefhaus Germany 12 196 1.7× 11 0.2× 55 1.0× 24 0.5× 21 0.4× 38 352
V P Hoppenreijs Netherlands 9 127 1.1× 16 0.2× 33 0.6× 23 0.5× 17 0.4× 10 359

Countries citing papers authored by Joel M. Mor

Since Specialization
Citations

This map shows the geographic impact of Joel M. Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel M. Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel M. Mor more than expected).

Fields of papers citing papers by Joel M. Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel M. Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel M. Mor. The network helps show where Joel M. Mor may publish in the future.

Co-authorship network of co-authors of Joel M. Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Joel M. Mor. A scholar is included among the top collaborators of Joel M. Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel M. Mor. Joel M. Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rokohl, Alexander C., Konrad R. Koch, Joel M. Mor, et al.. (2020). Personalisierte Medizin in der Behandlung von periokulären Tumoren. Der Ophthalmologe. 117(6). 521–527. 4 indexed citations
2.
Rokohl, Alexander C., Konrad R. Koch, Joel M. Mor, et al.. (2020). Personalisierte Medizin in der Behandlung von periokulären Tumoren: Zielgerichtete Therapien und der Einsatz von Immun-Checkpoint-Inhibitoren. Der Ophthalmologe. 117(6). 521–527.
3.
Rokohl, Alexander C., Niklas Loreck, Philomena A. Wawer Matos, et al.. (2020). Die Rolle der Augenheilkunde in der COVID-19-Pandemie. Der Ophthalmologe. 117(7). 642–647. 9 indexed citations
4.
Rokohl, Alexander C., Yongwei Guo, Werner Adler, et al.. (2020). Dry anophthalmic socket syndrome – Standardized clinical evaluation of symptoms and signs. The Ocular Surface. 18(3). 453–459. 21 indexed citations
5.
Mor, Joel M., Alexander C. Rokohl, Cornelia Mauch, & Ludwig M. Heindl. (2020). Interdisciplinary Surveillance of Ocular Melanomas: Experiences in a German Tertiary Centre. Klinische Monatsblätter für Augenheilkunde. 238(1). 85–91.
6.
Rokohl, Alexander C., Werner Adler, Konrad R. Koch, et al.. (2019). Cryolite glass prosthetic eyes—the response of the anophthalmic socket. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(9). 2015–2023. 18 indexed citations
7.
Rokohl, Alexander C., Yongwei Guo, Vinodh Kakkassery, et al.. (2019). Chirurgische Resektion mit ophthalmoplastischer Rekonstruktion. Der Ophthalmologe. 117(2). 95–105. 11 indexed citations
8.
Rokohl, Alexander C., Heike Löser, Joel M. Mor, et al.. (2019). Junger Patient mit ungewöhnlicher Raumforderung am Unterlid. Der Ophthalmologe. 117(1). 73–77. 5 indexed citations
9.
Rokohl, Alexander C., et al.. (2019). Customizing a Cryolite Glass Prosthetic Eye. Journal of Visualized Experiments. 6 indexed citations
10.
Mor, Joel M., Alexander C. Rokohl, Konrad R. Koch, & Ludwig M. Heindl. (2019). <p>Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights</p>. Clinical ophthalmology. Volume 13. 1297–1302. 8 indexed citations
11.
Koch, Konrad R., et al.. (2019). Klinisch-echographische Diagnostik bei Iristumoren. Der Ophthalmologe. 116(4). 313–323. 1 indexed citations
12.
Rokohl, Alexander C., Yongwei Guo, Joel M. Mor, et al.. (2019). Intubationssysteme in der Tränenwegchirurgie – eine aktuelle Übersicht. Klinische Monatsblätter für Augenheilkunde. 237(1). 20–28. 10 indexed citations
13.
Rokohl, Alexander C., Yongwei Guo, Joel M. Mor, et al.. (2019). Ästhetische Rehabilitation bei Anophthalmus. 13(1). 14–17. 1 indexed citations
14.
Mor, Joel M., Konrad R. Koch, Vinodh Kakkassery, Claus Cursiefen, & Ludwig M. Heindl. (2018). Neue therapeutische Möglichkeiten bei iridoziliären Tumoren. Der Ophthalmologe. 116(4). 332–339. 3 indexed citations
15.
Mor, Joel M., Mario Matthaei, Holger Schrumpf, et al.. (2018). Transcanalicular laser dacryocystorhinostomy for acquired nasolacrimal duct obstruction: an audit of 104 patients. European journal of medical research. 23(1). 58–58. 11 indexed citations
16.
Rokohl, Alexander C., Monika Ortmann, Joel M. Mor, Konrad R. Koch, & Ludwig M. Heindl. (2018). Langsam progrediente Oberlidschwellung und Ptosis. Der Ophthalmologe. 116(4). 387–390. 1 indexed citations
17.
Mor, Joel M., R. Semrau, Wolfgang W. Baus, et al.. (2017). CyberKnife®: Eine neue Therapieoption bei uvealem Melanom. Der Ophthalmologe. 115(4). 302–308. 5 indexed citations
18.
Mor, Joel M., Yongwei Guo, Konrad R. Koch, & Ludwig M. Heindl. (2017). Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction. Journal of Visualized Experiments. 7 indexed citations
19.
Mor, Joel M. & Ludwig M. Heindl. (2016). Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma. Ocular Oncology and Pathology. 3(2). 133–141. 34 indexed citations
20.
Meier, Claudia, Alf Spitschak, Kerstin Abshagen, et al.. (2014). Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up‐regulation of fibronectin. The Journal of Pathology. 234(3). 351–364. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026